Abstracts

1311 – Digital Strategy to Improve PrEP Adherence Among MSM: A Stepped-Wedge Randomized Trial in China

Background Digital Health intervention is promising for encouraging behavior change. We conducted a stepped-wedge trial (SWT) to evaluate the efficacy of co-created digital PrEP adherence intervention to facilitate adherence among Chinese MSM PrEP users. Methods This trial is nested in a PrEP demonstration trial in Guangzhou and Wuhan, China (NCT04754139). Participants were provided TDF/FTC for…

1312 – Impact Analysis and Machine Learning Forecasts of HIV Viral Load Suppression in 21 African Countries

Background Viral load suppression (VLS) is crucial for controlling HIV transmission and improving health outcomes in people living with HIV. While PEPFAR-supported programs have made substantial progress in improving VLS, innovative approaches are needed to sustain and enhance VLS in resource-limited settings. This analysis integrates machine learning and the difference-in-difference (DiD) method to forecast future…

1342 – Patterns of PrEP Use Among Rural South Africa Youth Given Choice: Process Data From the LAPIS Trial

Background In southern Africa the provision of pre-exposure prophylaxis (PrEP) has not translated into population-level impact due to the challenges of taking a daily oral pill. Injectable PrEP provides an opportunity to overcome this barrier.  Using clinical process data from the Long-Acting PrEP Integrated with Sexual and Reproductive Health (LAPIS) trial, we explore changes in patterns…

1343 – Peer Mobilisation Into Sexual Health Clinics Creates PrEP Demand Among High-Risk Rural Youth in SA

Background Providing oral pre-exposure prophylaxis (PrEP) has not achieved population-level impact in southern Africa due to challenges reaching those with the highest risk of HIV-acquisition.  We hypothesise that peer-led mobilisation into mobile sexual reproductive health (SRH) clinics will promote oral PrEP use amongst adolescents and young adults (AYA) at higher risk of HIV acquisition in…

1359 – Characteristics of People With HIV Prescribed Long-Acting Cabotegravir/Rilpivirine in a US Cohort

Background Long-acting cabotegravir/rilpivirine (LA-CAB/RPV) has the potential to reduce medication burden for people with HIV (PWH) and improve outcomes in PWH who struggle to achieve or maintain viral suppression, reflected in recent guideline changes regarding use in PWH with adherence challenges. Equity in early implementation of LA-CAB/RPV is a priority. Methods We used electronic medical…

1272 – Epidemiology of Bacterial STIs in MSM With or At Risk of HIV in the Region of Madrid (2021-2023)

Background We analyzed the epidemiology of bacterial STIs among MSM with HIV (MSM-WH) and those at risk of HIV (MSM-RH) in Madrid, evaluating associated risk factors. Methods This prospective study (2021–2023) included MSM-WH from the Spanish Network of AIDS Research Cohort (CoRIS) and those treated for HCV with DAAs in the Madrid Coinfection Registry (Madrid-CoRE).…

1300 – Addressing Alcohol Use and Depression as a Strategy to Reduce HIV in KwaZulu-Natal, South Africa

Background KwaZulu-Natal (KZN) has the highest burden of HIV infections in South Africa, with continually high rates across the province. Conditions of Alcohol, Substance, and Mood disorders (CASM) substantially increase HIV risk behaviors, especially for high-risk groups. We identified the impact and cost-effectiveness of screening and treatment for alcohol use disorder (AUD) and major depressive…

1340 – Prevalence of Unsuppressed Viral Load: Comparison of 2016-17 and 2022-23 Tanzania HIV Impact Surveys

Background Antiretroviral therapy (ART) improves clinical outcomes of people living with HIV (PLHIV) and achieving viral suppression through ART can prevent HIV transmission. We compared prevalence and correlates of unsuppressed viral load among PLHIV from two Tanzania HIV Impact Surveys (THISs). The first (survey 1 [S1]) was conducted from October 2016-August 2017; the second (survey…